A citation-based method for searching scientific literature

Cati G Brown-Johnson, Nadia Safaeinili, Juliana Baratta, Latha Palaniappan, Megan Mahoney, Lisa G Rosas, Marcy Winget. BMC Fam Pract 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin Pharmacol Ther 2014
167
100

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
269
100

Characterizing treatment pathways at scale using the OHDSI network.
George Hripcsak, Patrick B Ryan, Jon D Duke, Nigam H Shah, Rae Woong Park, Vojtech Huser, Marc A Suchard, Martijn J Schuemie, Frank J DeFalco, Adler Perotte,[...]. Proc Natl Acad Sci U S A 2016
132
100


What is polypharmacy? A systematic review of definitions.
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett, Gillian E Caughey. BMC Geriatr 2017
620
100

Lexicomp App Review.
Andres Elovic, Ali Pourmand. J Digit Imaging 2020
1
100

Insurance coverage policies for personalized medicine.
Andrew Hresko, Susanne B Haga. J Pers Med 2012
59
100

Clinical Relevance of CYP2D6 Polymorphisms in Patients of an Austrian Medical Practice: A Family Practice-Based Observational Study.
Gustav Kamenski, Seda Ayazseven, Anne Berndt, Waltraud Fink, Lukas Kamenski, Sonja Zehetmayer, Helene Pühringer. Drugs Real World Outcomes 2020
4
100


PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation.
Adam S Gordon, Robert S Fulton, Xiang Qin, Elaine R Mardis, Deborah A Nickerson, Steve Scherer. Pharmacogenet Genomics 2016
61
100

Potentially inappropriate medication use in elderly Japanese patients.
Manabu Akazawa, Hirohisa Imai, Ataru Igarashi, Kiichiro Tsutani. Am J Geriatr Pharmacother 2010
89
100

An overview of prevalence, determinants and health outcomes of polypharmacy.
Mina Khezrian, Chris J McNeil, Alison D Murray, Phyo K Myint. Ther Adv Drug Saf 2020
27
100



Auditing complex concepts of SNOMED using a refined hierarchical abstraction network.
Yue Wang, Michael Halper, Duo Wei, Huanying Gu, Yehoshua Perl, Junchuan Xu, Gai Elhanan, Yan Chen, Kent A Spackman, James T Case,[...]. J Biomed Inform 2012
37
100


Clinical consequences of polypharmacy in elderly.
Robert L Maher, Joseph Hanlon, Emily R Hajjar. Expert Opin Drug Saf 2014
701
100

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions.
Matthew P Rutman, John R Horn, Diane K Newman, Richard G Stefanacci. Clin Drug Investig 2021
1
100

The importance of integrating SNP and cheminformatics resources to pharmacogenomics.
Hsueh-Wei Chang, Li-Yeh Chuang, Ming-Tz Tsai, Cheng-Hong Yang. Curr Drug Metab 2012
14
100


Identification of populations likely to benefit from pharmacogenomic testing.
Craig William Heise, Tyler Gallo, Steven C Curry, Raymond L Woosley. Pharmacogenet Genomics 2020
2
100

The challenge of managing drug interactions in elderly people.
Louise Mallet, Anne Spinewine, Allen Huang. Lancet 2007
269
100

The HL7 Clinical Document Architecture.
R H Dolin, L Alschuler, C Beebe, P V Biron, S L Boyer, D Essin, E Kimber, T Lincoln, J E Mattison. J Am Med Inform Assoc 2001
152
100

Comparison of delivery strategies for pharmacogenetic testing services.
Susanne B Haga, Jivan Moaddeb. Pharmacogenet Genomics 2014
31
100

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
W S Bush, D R Crosslin, A Owusu-Obeng, J Wallace, B Almoguera, M A Basford, S J Bielinski, D S Carrell, J J Connolly, D Crawford,[...]. Clin Pharmacol Ther 2016
95
100

Using HL7 FHIR to achieve interoperability in patient health record.
Rishi Saripalle, Christopher Runyan, Mitchell Russell. J Biomed Inform 2019
20
100

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative.
Muh Akbar Bahar, Pauline Lanting, Jens H J Bos, Rolf H Sijmons, Eelko Hak, Bob Wilffert. J Pers Med 2020
2
100

Challenges to integrating pharmacogenetic testing into medication therapy management.
Susanne B Haga, Nancy M Allen LaPointe, Jivan Moaddeb. J Manag Care Spec Pharm 2015
15
100

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Kelly E Caudle, Teri E Klein, James M Hoffman, Daniel J Muller, Michelle Whirl-Carrillo, Li Gong, Ellen M McDonagh, Katrin Sangkuhl, Caroline F Thorn, Matthias Schwab,[...]. Curr Drug Metab 2014
209
100

A dataset quantifying polypharmacy in the United States.
Katie J Quinn, Nigam H Shah. Sci Data 2017
30
100

Integrating pharmacogenetic testing into primary care.
Susanne B Haga. Expert Rev Precis Med Drug Dev 2017
3
100

Addressing phenoconversion: the Achilles' heel of personalized medicine.
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
118
100

Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review.
Johanna Raymond, Laurent Imbert, Thibault Cousin, Thomas Duflot, Rémi Varin, Julien Wils, Fabien Lamoureux. J Pers Med 2021
3
100

Evaluation of adverse drug reaction formatting in drug information databases.
Sean M McConachie, Derek Volgyi, Hannah Moore, Christopher A Giuliano. J Med Libr Assoc 2020
1
100

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
922
100

Managing Increased Accessibility to Pharmacogenomic Data.
Susanne B Haga. Clin Pharmacol Ther 2019
2
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.